Conference Agenda

Friday, April 24th, 2026: Pre Conference

Cellular Processing Laboratory Workshop

8:30am-9:00am

Opening & TBC

Celattin Ustun, MD & Mahzad Akbapour, PhD

9:00am-10:00am

Global Cell Therapy lab leadership or Hospital based point of care cell therapy manufacturing (Topic TBD)

Jacques Galipeau, MD

10:00am-10:45am

Mesenchymal stem cell therapy for ocular injuries

Ali Djalilian MD, PhD            
10:45am-11:00am

Coffee Break

11:00am-12:30pm

Miltenyi Clinical Hands on Lab

12:30pm-1:00pm

Lunch Break

1:00pm-1:45pm

Immuno-monitoring and analytical assay development form point of care cGMP cell manufacturing

Patrick Hanley, PhD

1:45pm-2:30pm

CAR T Cells development in academic cGMP facility (topic TBD)

Emily Hopewell PhD

2:30pm-3:15pm

Development of cell based therapies to achieve tolerance induction in solid organ transplant

Speaker PENDING

3:15pm-4:00pm

Immuno correlative assays in cancer cell therapy

Tyce Kearl MD, PhD

4:00pm-4:30pm

TBC Interactive Panel Discussion

Closing Remarks

Saturday, April 25th, 2026: Main Conference

7:00 AM - 8:00 AM
Non-CME Product Theater

SESSION I: LYMPHOMAS /LYMPHOID MALIGNANCIES
Chair: Mehdi Hamadani, MD

8:00am-8:10am

Welcome & Opening remarks

8:10am-8:30am

How to use cHL Prognostic factors with frontline treatment approaches in 2026

Andrew Evans, MD

8:30am-8:50am

How to select between CAR-T and targeted approaches and Relapsed/refractory mantle cell lymphoma

Brian Hill MD, PhD

8:50am-9:10am

Beyond CAR-T in R/R LBCLs

Farrukh Awan, MD

9:10am-9:30am

When to use allogeneic HCT in R/R T-cell NHL

Dipenkumar Modi, MD

9:30am-9:50am

Panel Discussion & Q & A

9:50am-10:10am

Exhibitor/Coffee Break

SESSION II: PLASMA CELL MALIGNANCIES/MYELOMA/AMYLOID
Chair: Patrick Hagen, MD

10:10am-10:30am

BiTE and CARs in AL

Taxiarchis Kourelis, MD

10:30am-10:50am

Role of up front ASCT-MRD Drive

Muhamed Baljevic MD, FACP

10:50am-11:10am

MM CAR-T Toxicities

Imran Puthawala, MD

11:10am-11:30am

Sequencing therapies in early relapses

Binod Dhakal, MD

11:30am-11:50am

Plasma Cell Malignancy Panel Discussion

11:50am-12:50pm
Non-CME Product Theater

SESSION III: ACUTE LEUKEMIAS AND BMF
Chair: Celalettin Ustun, MD

12:50pm-1:10pm

CAR-T vs alloHCT in Acute Lymphoblastic Leukemia (ALL)

Wendy Stock, MD
1:10pm-1:30pm

Primary Myelofibrosis (PMF) Active problems and treatment

Jamille Shammo, MD

1:30pm-1:50pm

Acute Myeloid Leukemia (AML) current therapies

Geoffrey UY, MD

1:50pm-2:10pm

Recent Advances in Myelodysplastic Syndrome (MDS)

Olatoyosi Odenike, MD

2:10pm-2:30pm

Acute Leukemias and Bone Marrow Failure Panel

2:30pm-2:50pm

Coffee & Exhibitor Break

SESSION IV: MISCELLANEOUS
Chair: Sunita Nathan, MD

2:50pm-3:10pm

Frailty assessment and Pre Hab in HCT and Cell therapy patients

Magdelena Bednarczyk, MD

3:10pm-3:30pm

Alternative donor HCT -Access trial and impact of PTCY and Nuances

Antonio Jimenez, MD

3:30pm-3:50pm

CAR T Cell Therapy complication-focus on IEC HS

Sushma Bharadwaj, MD

3:50pm-4:10pm

Evolving Landscape of cellular therapy in solid tumors and focus on TiL therapy

John Hyngstrom, MD

4:10pm-4:30pm

Panel and Q & A

4:30pm

Adjourn